Natixis Advisors, L.P. Johnson & Johnson Transaction History

Natixis Advisors, L.P.

$46 Billion
Q2 2024

A detailed history of Natixis Advisors, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,301,152 shares of JNJ stock, worth $208 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

1,301,152

Previous 1,487,196 12.51%

Holding current value

$208 Million

Previous $235 Million 19.16%

% of portfolio

0.41%

Previous 0.54%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $26.9 Million - $29.4 Million	-186,044 Reduced 12.51%	1,301,152 $190 Million
Q1 2024 Apr 25, 2024	BUY	$155.22 - $162.74 $6.49 Million - $6.8 Million	41,806 Added 2.89%	1,487,196 $235 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $12.2 Million - $13.3 Million	-83,536 Reduced 5.46%	1,445,390 $227 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $16.1 Million - $18.1 Million	-103,538 Reduced 6.34%	1,528,926 $238 Million
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $61.1 Million - $65.8 Million	396,111 Added 32.04%	1,632,464 $270 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $25.5 Million - $30.5 Million	-168,967 Reduced 12.02%	1,236,353 $192 Million
Q4 2022 Jan 27, 2023	BUY	$160.2 - $179.79 $15.8 Million - $17.7 Million	98,436 Added 7.53%	1,405,320 $248 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $11.7 Million - $13 Million	-72,622 Reduced 5.26%	1,306,884 $213 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $3.07 Million - $3.39 Million	18,244 Added 1.34%	1,379,506 $245 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $65.3 Million - $74.1 Million	412,785 Added 43.52%	1,361,262 $241 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $12.1 Million - $13.4 Million	77,502 Added 8.9%	948,477 $162 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $4.53 Million - $5.04 Million	28,078 Added 3.33%	870,975 $141 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $11.7 Million - $12.6 Million	73,452 Added 9.55%	842,897 $139 Million
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $3.02 Million - $3.37 Million	19,752 Added 2.63%	769,445 $126 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.11 Million - $1.28 Million	8,112 Added 1.09%	749,693 $118 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $1.53 Million - $1.67 Million	10,883 Added 1.49%	741,581 $110 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $17.9 Million - $21.6 Million	-139,185 Reduced 16.0%	730,698 $103 Million
Q1 2020 Apr 27, 2020	BUY	$111.14 - $153.99 $13.6 Million - $18.9 Million	122,794 Added 16.44%	869,883 $114 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $27.9 Million - $32.1 Million	219,062 Added 41.49%	747,089 $109 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $3.08 Million - $3.45 Million	-24,277 Reduced 4.4%	528,027 $68.3 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $4.97 Million - $5.47 Million	37,899 Added 7.37%	552,304 $76.9 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $6.13 Million - $6.82 Million	48,797 Added 10.48%	514,405 $71.9 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $1.43 Million - $1.72 Million	-11,666 Reduced 2.44%	465,608 $60.1 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $8.44 Million - $9.91 Million	69,389 Added 17.01%	477,274 $65.9 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $430,198 - $474,731	-3,603 Reduced 0.88%	407,885 $0
Q1 2018 May 10, 2018	BUY	$125.1 - $148.14 $1.36 Million - $1.62 Million	10,909 Added 2.72%	411,488 $52.7 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $2.53 Million - $2.77 Million	19,292 Added 5.06%	400,579 $56 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $49.4 Million - $51.6 Million	381,287	381,287 $49.6 Million

Others Institutions Holding JNJ

# of Institutions

4,219

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Johnson & Johnson Transaction History